Abstract

Autoantibodies against astrocyte water channel aquaporin-4 (AQP4) are thought to be pathogenic in neuromyelitis optica (NMO). Prior work has suggested that a key component of NMO autoantibody (NMO-IgG) pathogenesis is internalization of AQP4 and the associated glutamate transporter EAAT2, leading to glutamate excitotoxicity. Here, we show selective endocytosis of NMO-IgG and AQP4 in transfected cell cultures, but little internalization in brain in vivo. AQP4-dependent endocytosis of NMO-IgG occurred rapidly in various AQP4-transfected cell lines, with efficient transport from early endosomes to lysosomes. Cell surface AQP4 was also reduced following NMO-IgG exposure. However, little or no internalization of NMO-IgG, AQP4, or EAAT2 was found in primary astrocyte cultures, nor was glutamate uptake affected by NMO-IgG exposure. Following injection of NMO-IgG into mouse brain, NMO-IgG binding and AQP4 expression showed a perivascular astrocyte distribution, without detectable cellular internalization over 24 h. We conclude that astrocyte endocytosis of NMO-IgG, AQP4, and EAAT2 is not a significant consequence of AQP4 autoantibody in vivo, challenging generally accepted views about NMO pathogenesis.

Highlights

  • Binding of the neuromyelitis optica (NMO) autoantibody (NMO-IgG) to aquaporin-4 (AQP4) is pathogenic in NMO

  • NMO-IgG binding to AQP4 in transfected cell cultures caused internalization of itself and AQP4 by an endocytic mechanism, little or no internalization was found in astrocyte cultures or in brain

  • We found that NMO-IgG is internalized in several transfected cell lines expressing M1- or M23-AQP4

Read more

Summary

Background

Binding of the neuromyelitis optica (NMO) autoantibody (NMO-IgG) to aquaporin-4 (AQP4) is pathogenic in NMO. Results: NMO-IgG binding does not cause endocytosis of itself, AQP4, or glutamate transporter EAAT2 in astrocyte cultures or in vivo. Little or no internalization of NMO-IgG, AQP4, or EAAT2 was found in primary astrocyte cultures, nor was glutamate uptake affected by NMO-IgG exposure. We conclude that astrocyte endocytosis of NMO-IgG, AQP4, and EAAT2 is not a significant consequence of AQP4 autoantibody in vivo, challenging generally accepted views about NMO pathogenesis. NMO lesions are produced in mice administered NMO-IgG and complement by intracerebral injection [7], in rats with preexisting neuroinflammation administered NMO-IgG (8 –10), and in spinal cord slice cultures exposed to NMO-IgG and complement [11] It is not known how NMO-IgG enters the central nervous system through an initially intact blood-brain barrier or why NMOIgG does not cause pathology in peripheral tissues where AQP4 is expressed. Our results challenge a widely cited view of NMO disease pathogenesis

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call